Co-Optimization of Fuels & Engines Call for White Papers - Directed Funding Opportunity for Collaboration with National Laboratories

Funding Agency:
Department of Energy

The Co-Optimization of Fuels & Engines (Co-Optima) initiative focuses on developing new high-performance fuels that, when combined with advanced combustion approaches, can boost engine efficiency and cut emissions. Co-Optima seeks proposals to leverage National Laboratory resources and overcome key technical challenges to advancing new liquid fuels and blendstocks, with an emphasis on biofuels from renewable and waste resources, which enable higher efficiency and lower environmental impact engines in on-highway vehicles. Proposals should address specific technical challenges and barriers that Co-Optima researchers can address to move new fuels closer to market in conjunction with advanced, high-efficiency engines.

This Directed Funding Opportunity (DFO) seeks proposals advancing the aims of Co-Optima:

Foundational and applied research and development (R&D) at the fuel-engine interface

This call seeks proposals to advance foundational knowledge at the fuel-engine interface, as well as applied R&D focused on advancing technologies that move promising bio-blendstocks and combustion approaches identified in Co-Optima closer to commercial adoption.

Deadline: Jan. 14, 2021

Agency Website

Eligibility Requirements

All U.S. domestic for-profit or non-profit businesses interested in Co-Optima goals and objectives in advancing fuel-engine Co-Optimization are eligible. Foreign entities, whether for-profit or otherwise, including U.S. incorporated subsidiaries with a foreign-owned parent company, are eligible to apply; however, a waiver request will be required. Approval of this waiver is subject to U.S. Department of Energy (DOE) discretion and is necessary to complete the CRADA contract. All project work under this DFO must be performed in the United States (100% of all direct labor).

Funding Type





Engineering and Physical Sciences
Environmental & Life Sciences

External Deadline

January 14, 2021